Status:
WITHDRAWN
Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)
Lead Sponsor:
Emergency NGO Onlus
Conditions:
Ebola Virus Disease
Eligibility:
All Genders
2+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of amiodarone in the treatment of patients afflicted with Ebola virus disease.
Eligibility Criteria
Inclusion
- patient admitted to the Emergency ETC at Goderich with a clinical diagnosis of Ebola virus disease;
- patient who consent to participate in the study.
Exclusion
- negative RT-PCR tests for Ebola virus
- age \<2 years
- state of shock upon admission
- onset of fever for more than 6 days
- Glasgow Coma Scale \<12
- known contraindications to administration of amiodarone
- positive for HIV antibodies.
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02307591
Start Date
December 1 2014
End Date
July 1 2015
Last Update
October 6 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.